Brief: Advaxis Inc Reports Qtrly Loss Per Share Of $0.15

Ayala Pharmaceuticals

13/03/2020 14:10

March 13 (Reuters) - Advaxis Inc  ADXS.O :
    * ADVAXIS REPORTS FIRST QUARTER ENDED JANUARY 31, 2020
FINANCIAL
RESULTS AND PROVIDES A PIPELINE UPDATE
    * ADVAXIS INC - AS OF JANUARY 31, 2020, COMPANY HAD
APPROXIMATELY
$34.2 MILLION IN CASH AND CASH EQUIVALENTS
    * ADVAXIS INC - BELIEVES THIS IS SUFFICIENT CAPITAL TO FUND
ITS
OBLIGATIONS, AS THEY BECOME DUE, IN ORDINARY COURSE OF BUSINESS
UNTIL AT LEAST MID-2021
    * ADVAXIS -  BELIEVES THIS IS SUFFICIENT CAPITAL TO FUND ITS
OBLIGATIONS, AS THEY BECOME DUE, IN ORDINARY COURSE OF BUSINESS
UNTIL AT LEAST MID-2021
    * ADVAXIS INC QTRLY LOSS PER SHARE $0.15

Source text for Eikon:  ID:nGNXcbGdjq 
Further company coverage:  ADXS.O 

 ((Reuters.Briefs@thomsonreuters.com;))